FHI - Research Briefs on the Intrauterine Device (IUD)

Intrauterine Devices Are Safe for Use by Adolescents (2009)

Clinicians should offer the intrauterine device as a first-line contraceptive method to all women, including adolescents, say the authors of a systematic review of the topic.

Statistical Modeling Provides Reassurance to West African Women Who Use the Intrauterine Device (2008)

The risk of pelvic inflammatory disease (PID) that can be attributed to the use of an intrauterine device (IUD) is very low in West Africa, according to statistical modeling performed with support from USAID.

Multiple Strategies Needed to Increase the Use of the Intrauterine Device (2007)

USAID-supported research from Family Health International and the Kenya Ministry of Health highlights the importance of targeting the factors associated with supply and demand when attempting to increase the use of contraceptives.

NSAIDs Reduce Bleeding and Pain Associated with IUDs (2006)

Non-steroidal anti-inflammatory drugs (NSAIDs), such as naproxen and ibuprofen, can help reduce both pain and menstrual blood loss associated with intrauterine device (IUD) use.

IUD Re-introduction in Kenya (2003)

The Kenya Ministry of Health (MOH) is committed to providing a range of contraceptive options and a more balanced and sustainable method mix to Kenyans; as such, the MOH has led a process to build consensus and collaboration among members of the private sector, professional organizations, national and international reproductive health organizations, and international donors on how to rehabilitate the IUD in Kenya.

IUDs: Safe, Effective, and Under-used (2003)

IUDs are extremely safe, effective, and economical. They have a service life of five to 10 years and produce very few side effects. Though little-used in the United States, they are the most popular form of reversible contraception worldwide.

Qualitative Assessment of IUD Service Delivery in Kenya (2003)

In spite of its advantages, intrauterine device (IUD) use has declined relative to other contraceptive methods in Kenya. To learn why, FHI conducted simulated client visits and in-depth interviews at 12 sites throughout Kenya.

Safety of IUDs: A Review of Five Recent Publications (2002)

This brief summarizes six recent studies and review articles confirming the safety of the IUD in general and especially with respect to PID and infertility.

Increasing Access and Safeguarding Health: The Impact of IUD Revisit Norms in Ecuador (1994)

Most family planning programs recommend that intrauterine device (IUD) acceptors return for routine follow-up visits. However, programs have questions about the appropriate number and timing of visits to detect problems and assure quality care. The study, carried out by FHI and the Population Council through the INOPAL program, evaluated the impact on safety and costs of IUD revisit norms that recommend fewer routinely scheduled visits.